Lynch, M. T., Maloney, K. A., Pollin, T. I., Streeten, E. A., Xu, H., Shuldiner, A. R., . . . Mitchell, B. D. (2021). The burden of pathogenic variants in clinically actionable genes in a founder population. American journal of medical genetics. Part A, 185(11), 3476-3484. https://doi.org/10.1002/ajmg.a.62472
Chicago Style (17th ed.) CitationLynch, Megan T., Kristin A. Maloney, Toni I. Pollin, Elizabeth A. Streeten, Huichun Xu, Alan R. Shuldiner, Cristopher V. Van Hout, Claudia Gonzaga‐Jauregui, and Braxton D. Mitchell. "The Burden of Pathogenic Variants in Clinically Actionable Genes in a Founder Population." American Journal of Medical Genetics. Part A 185, no. 11 (2021): 3476-3484. https://doi.org/10.1002/ajmg.a.62472.
MLA (9th ed.) CitationLynch, Megan T., et al. "The Burden of Pathogenic Variants in Clinically Actionable Genes in a Founder Population." American Journal of Medical Genetics. Part A, vol. 185, no. 11, 2021, pp. 3476-3484, https://doi.org/10.1002/ajmg.a.62472.